Assessment of the Androstenedione Assay on a Roche Analytical Platform and Comparison with Different Methods. 2023

Isabelle Ruth, and Caroline Le Goff, and Stephanie Peeters, and Leonidas Bizumukama, and Guillaume Deprez, and Cecile Duterme, and Frederic Cotton, and Fleur Wolff

BACKGROUND D4-androstenedione (D4ASD) is an intermediate hormone of androgen biosynthesis by the gonads and the adrenal glands. The interest in D4ASD concentration assessment resides in diagnostics of androgenic hyperproduction pathologies. Currently, many D4ASD quantification methods are available on the market including immunological methods that remain problematic due to the possible cross-reactivity with endogenous or exogenous steroids. METHODS Recently Roche® launched a new fully automated instrument for the measurement of D4ASD concentration. In this paper, the criteria of analytical performance (repeatability and intermediate precision) of the D4ASD Roche® assay were assessed and compared with 2 different methods including a radioimmunoassay (RIA) as well as a liquid chromatography tandem mass spectrometry (LC-MS/MS) method. RESULTS Repeatability and intermediate precision of the D4ASD Roche® were acceptable according to the prede-fined RICOS standard (CV ≤ 7.9%) and the assay showed a good correlation with other assays considering the 95% CI obtained for the slope and the y-intercept. CONCLUSIONS This method demonstrates acceptable criteria of analytical performance with an intermediate imprecision and a trueness within the fixed acceptance limits.

UI MeSH Term Description Entries
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D002853 Chromatography, Liquid Chromatographic techniques in which the mobile phase is a liquid. Liquid Chromatography
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000735 Androstenedione A delta-4 C19 steroid that is produced not only in the TESTIS, but also in the OVARY and the ADRENAL CORTEX. Depending on the tissue type, androstenedione can serve as a precursor to TESTOSTERONE as well as ESTRONE and ESTRADIOL. 4-Androstene-3,17-dione,delta-4-Androstenedione,4 Androstene 3,17 dione,delta 4 Androstenedione
D013256 Steroids A group of polycyclic compounds closely related biochemically to TERPENES. They include cholesterol, numerous hormones, precursors of certain vitamins, bile acids, alcohols (STEROLS), and certain natural drugs and poisons. Steroids have a common nucleus, a fused, reduced 17-carbon atom ring system, cyclopentanoperhydrophenanthrene. Most steroids also have two methyl groups and an aliphatic side-chain attached to the nucleus. (From Hawley's Condensed Chemical Dictionary, 11th ed) Steroid,Catatoxic Steroids,Steroids, Catatoxic
D053719 Tandem Mass Spectrometry A mass spectrometry technique using two (MS/MS) or more mass analyzers. With two in tandem, the precursor ions are mass-selected by a first mass analyzer, and focused into a collision region where they are then fragmented into product ions which are then characterized by a second mass analyzer. A variety of techniques are used to separate the compounds, ionize them, and introduce them to the first mass analyzer. For example, for in GC-MS/MS, GAS CHROMATOGRAPHY-MASS SPECTROMETRY is involved in separating relatively small compounds by GAS CHROMATOGRAPHY prior to injecting them into an ionization chamber for the mass selection. Mass Spectrometry-Mass Spectrometry,Mass Spectrometry Mass Spectrometry,Mass Spectrometry, Tandem

Related Publications

Isabelle Ruth, and Caroline Le Goff, and Stephanie Peeters, and Leonidas Bizumukama, and Guillaume Deprez, and Cecile Duterme, and Frederic Cotton, and Fleur Wolff
June 1974, Journal of clinical pathology,
Isabelle Ruth, and Caroline Le Goff, and Stephanie Peeters, and Leonidas Bizumukama, and Guillaume Deprez, and Cecile Duterme, and Frederic Cotton, and Fleur Wolff
January 2020, Journal of medical biochemistry,
Isabelle Ruth, and Caroline Le Goff, and Stephanie Peeters, and Leonidas Bizumukama, and Guillaume Deprez, and Cecile Duterme, and Frederic Cotton, and Fleur Wolff
June 1993, Therapeutic drug monitoring,
Isabelle Ruth, and Caroline Le Goff, and Stephanie Peeters, and Leonidas Bizumukama, and Guillaume Deprez, and Cecile Duterme, and Frederic Cotton, and Fleur Wolff
April 2017, Clinical biochemistry,
Isabelle Ruth, and Caroline Le Goff, and Stephanie Peeters, and Leonidas Bizumukama, and Guillaume Deprez, and Cecile Duterme, and Frederic Cotton, and Fleur Wolff
November 2012, Clinical chemistry and laboratory medicine,
Isabelle Ruth, and Caroline Le Goff, and Stephanie Peeters, and Leonidas Bizumukama, and Guillaume Deprez, and Cecile Duterme, and Frederic Cotton, and Fleur Wolff
January 2019, Practical laboratory medicine,
Isabelle Ruth, and Caroline Le Goff, and Stephanie Peeters, and Leonidas Bizumukama, and Guillaume Deprez, and Cecile Duterme, and Frederic Cotton, and Fleur Wolff
June 1983, Clinical endocrinology,
Isabelle Ruth, and Caroline Le Goff, and Stephanie Peeters, and Leonidas Bizumukama, and Guillaume Deprez, and Cecile Duterme, and Frederic Cotton, and Fleur Wolff
May 2009, Clinical chemistry,
Isabelle Ruth, and Caroline Le Goff, and Stephanie Peeters, and Leonidas Bizumukama, and Guillaume Deprez, and Cecile Duterme, and Frederic Cotton, and Fleur Wolff
November 2021, Medicina (Kaunas, Lithuania),
Isabelle Ruth, and Caroline Le Goff, and Stephanie Peeters, and Leonidas Bizumukama, and Guillaume Deprez, and Cecile Duterme, and Frederic Cotton, and Fleur Wolff
June 2019, International journal of laboratory hematology,
Copied contents to your clipboard!